Seek Returns logo

UNH vs. WAT: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at UNH and WAT, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolUNHWAT
Company NameUnitedHealth Group IncorporatedWaters Corporation
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesLife Sciences Tools & Services
Market Capitalization271.56 billion USD17.66 billion USD
ExchangeNYSENYSE
Listing DateOctober 17, 1984November 17, 1995
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of UNH and WAT by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

UNH vs. WAT: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolUNHWAT
5-Day Price Return10.44%1.09%
13-Week Price Return-5.08%-17.24%
26-Week Price Return-43.55%-21.73%
52-Week Price Return-48.19%-12.79%
Month-to-Date Return20.15%2.76%
Year-to-Date Return-40.73%-20.01%
10-Day Avg. Volume23.69M0.62M
3-Month Avg. Volume18.68M0.68M
3-Month Volatility48.27%38.48%
Beta0.441.06

Profitability

Return on Equity (TTM)

UNH

22.26%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

In the upper quartile for the Health Care Providers & Services industry, UNH’s Return on Equity of 22.26% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

WAT

35.02%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

WAT’s Return on Equity of 35.02% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

UNH vs. WAT: A comparison of their Return on Equity (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

UNH

5.04%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

UNH’s Net Profit Margin of 5.04% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

WAT

21.71%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

A Net Profit Margin of 21.71% places WAT in the upper quartile for the Life Sciences Tools & Services industry, signifying strong profitability and more effective cost management than most of its peers.

UNH vs. WAT: A comparison of their Net Profit Margin (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

UNH

7.26%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

UNH’s Operating Profit Margin of 7.26% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

WAT

27.69%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 27.69% places WAT in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

UNH vs. WAT: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolUNHWAT
Return on Equity (TTM)22.26%35.02%
Return on Assets (TTM)7.01%14.40%
Net Profit Margin (TTM)5.04%21.71%
Operating Profit Margin (TTM)7.26%27.69%
Gross Profit Margin (TTM)--59.02%

Financial Strength

Current Ratio (MRQ)

UNH

0.81

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

UNH’s Current Ratio of 0.81 falls into the lower quartile for the Health Care Providers & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

WAT

1.75

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

WAT’s Current Ratio of 1.75 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

UNH vs. WAT: A comparison of their Current Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

UNH

0.79

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

UNH’s Debt-to-Equity Ratio of 0.79 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

WAT

0.67

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

WAT’s Debt-to-Equity Ratio of 0.67 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

UNH vs. WAT: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

UNH

6.14

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

UNH’s Interest Coverage Ratio of 6.14 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.

WAT

11.29

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

WAT’s Interest Coverage Ratio of 11.29 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.

UNH vs. WAT: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolUNHWAT
Current Ratio (MRQ)0.811.75
Quick Ratio (MRQ)0.601.22
Debt-to-Equity Ratio (MRQ)0.790.67
Interest Coverage Ratio (TTM)6.1411.29

Growth

Revenue Growth

UNH vs. WAT: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

UNH vs. WAT: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

UNH

2.88%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 2.88%, UNH offers a more attractive income stream than most of its peers in the Health Care Providers & Services industry, signaling a strong commitment to shareholder returns.

WAT

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

WAT currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

UNH vs. WAT: A comparison of their Dividend Yield (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

UNH

36.54%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

UNH’s Dividend Payout Ratio of 36.54% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

WAT

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

WAT has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

UNH vs. WAT: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolUNHWAT
Dividend Yield (TTM)2.88%0.00%
Dividend Payout Ratio (TTM)36.54%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

UNH

12.70

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

UNH’s P/E Ratio of 12.70 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

WAT

26.76

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

In the lower quartile for the Life Sciences Tools & Services industry, WAT’s P/E Ratio of 26.76 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

UNH vs. WAT: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

UNH

0.64

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

UNH’s P/S Ratio of 0.64 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

WAT

5.81

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

WAT’s P/S Ratio of 5.81 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

UNH vs. WAT: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

UNH

2.82

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

UNH’s P/B Ratio of 2.82 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

WAT

9.62

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

At 9.62, WAT’s P/B Ratio is at an extreme premium to the Life Sciences Tools & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

UNH vs. WAT: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolUNHWAT
Price-to-Earnings Ratio (TTM)12.7026.76
Price-to-Sales Ratio (TTM)0.645.81
Price-to-Book Ratio (MRQ)2.829.62
Price-to-Free Cash Flow Ratio (TTM)10.7028.57